Cargando…

The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease

Sickle cell disease (SCD) is a genetic disease caused by a single mutation in the β-globin gene, leading to the production of an abnormal hemoglobin called hemoglobin S (HbS), which polymerizes under deoxygenation, and induces the sickling of red blood cells (RBCs). Sickled RBCs are very fragile and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nader, Elie, Romana, Marc, Connes, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082402/
https://www.ncbi.nlm.nih.gov/pubmed/32231672
http://dx.doi.org/10.3389/fimmu.2020.00454
_version_ 1783508341579841536
author Nader, Elie
Romana, Marc
Connes, Philippe
author_facet Nader, Elie
Romana, Marc
Connes, Philippe
author_sort Nader, Elie
collection PubMed
description Sickle cell disease (SCD) is a genetic disease caused by a single mutation in the β-globin gene, leading to the production of an abnormal hemoglobin called hemoglobin S (HbS), which polymerizes under deoxygenation, and induces the sickling of red blood cells (RBCs). Sickled RBCs are very fragile and rigid, and patients consequently become anemic and develop frequent and recurrent vaso-occlusive crises. However, it is now evident that SCD is not only a RBC rheological disease. Accumulating evidence shows that SCD is also characterized by the presence of chronic inflammation and oxidative stress, participating in the development of chronic vasculopathy and several chronic complications. The accumulation of hemoglobin and heme in the plasma, as a consequence of enhanced intravascular hemolysis, decreases nitric oxide bioavailability and enhances the production of reactive oxygen species (ROS). Heme and hemoglobin also represent erythrocytic danger-associated molecular pattern molecules (eDAMPs), which may activate endothelial inflammation through TLR-4 signaling and promote the development of complications, such as acute chest syndrome. It is also suspected that heme may activate the innate immune complement system and stimulate neutrophils to release neutrophil extracellular traps. A large amount of microparticles (MPs) from various cellular origins (platelets, RBCs, white blood cells, endothelial cells) is also released into the plasma of SCD patients and participate in the inflammation and oxidative stress in SCD. In turn, this pro-inflammatory and oxidative stress environment further alters the RBC properties. Increased pro-inflammatory cytokine concentrations promote the activation of RBC NADPH oxidase and, thus, raise the production of intra-erythrocyte ROS. Such enhanced oxidative stress causes deleterious damage to the RBC membrane and further alters the deformability of the cells, modifying their aggregation properties. These RBC rheological alterations have been shown to be associated to specific SCD complications, such as leg ulcers, priapism, and glomerulopathy. Moreover, RBCs positive for the Duffy antigen receptor for chemokines may be very sensitive to various inflammatory molecules that promote RBC dehydration and increase RBC adhesiveness to the vascular wall. In summary, SCD is characterized by a vicious circle between abnormal RBC rheology and inflammation, which modulates the clinical severity of patients.
format Online
Article
Text
id pubmed-7082402
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70824022020-03-30 The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease Nader, Elie Romana, Marc Connes, Philippe Front Immunol Immunology Sickle cell disease (SCD) is a genetic disease caused by a single mutation in the β-globin gene, leading to the production of an abnormal hemoglobin called hemoglobin S (HbS), which polymerizes under deoxygenation, and induces the sickling of red blood cells (RBCs). Sickled RBCs are very fragile and rigid, and patients consequently become anemic and develop frequent and recurrent vaso-occlusive crises. However, it is now evident that SCD is not only a RBC rheological disease. Accumulating evidence shows that SCD is also characterized by the presence of chronic inflammation and oxidative stress, participating in the development of chronic vasculopathy and several chronic complications. The accumulation of hemoglobin and heme in the plasma, as a consequence of enhanced intravascular hemolysis, decreases nitric oxide bioavailability and enhances the production of reactive oxygen species (ROS). Heme and hemoglobin also represent erythrocytic danger-associated molecular pattern molecules (eDAMPs), which may activate endothelial inflammation through TLR-4 signaling and promote the development of complications, such as acute chest syndrome. It is also suspected that heme may activate the innate immune complement system and stimulate neutrophils to release neutrophil extracellular traps. A large amount of microparticles (MPs) from various cellular origins (platelets, RBCs, white blood cells, endothelial cells) is also released into the plasma of SCD patients and participate in the inflammation and oxidative stress in SCD. In turn, this pro-inflammatory and oxidative stress environment further alters the RBC properties. Increased pro-inflammatory cytokine concentrations promote the activation of RBC NADPH oxidase and, thus, raise the production of intra-erythrocyte ROS. Such enhanced oxidative stress causes deleterious damage to the RBC membrane and further alters the deformability of the cells, modifying their aggregation properties. These RBC rheological alterations have been shown to be associated to specific SCD complications, such as leg ulcers, priapism, and glomerulopathy. Moreover, RBCs positive for the Duffy antigen receptor for chemokines may be very sensitive to various inflammatory molecules that promote RBC dehydration and increase RBC adhesiveness to the vascular wall. In summary, SCD is characterized by a vicious circle between abnormal RBC rheology and inflammation, which modulates the clinical severity of patients. Frontiers Media S.A. 2020-03-13 /pmc/articles/PMC7082402/ /pubmed/32231672 http://dx.doi.org/10.3389/fimmu.2020.00454 Text en Copyright © 2020 Nader, Romana and Connes. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Nader, Elie
Romana, Marc
Connes, Philippe
The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease
title The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease
title_full The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease
title_fullStr The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease
title_full_unstemmed The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease
title_short The Red Blood Cell—Inflammation Vicious Circle in Sickle Cell Disease
title_sort red blood cell—inflammation vicious circle in sickle cell disease
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082402/
https://www.ncbi.nlm.nih.gov/pubmed/32231672
http://dx.doi.org/10.3389/fimmu.2020.00454
work_keys_str_mv AT naderelie theredbloodcellinflammationviciouscircleinsicklecelldisease
AT romanamarc theredbloodcellinflammationviciouscircleinsicklecelldisease
AT connesphilippe theredbloodcellinflammationviciouscircleinsicklecelldisease
AT naderelie redbloodcellinflammationviciouscircleinsicklecelldisease
AT romanamarc redbloodcellinflammationviciouscircleinsicklecelldisease
AT connesphilippe redbloodcellinflammationviciouscircleinsicklecelldisease